A person’s chance of breaking a bone sometime within the next year is nearly four per cent.
If they are unlucky enough to need a bone replacement, it will probably be based on a metal part.
Unfortunately, metal parts are sometimes toxic over time, and will not help the original bone regrow.
Calcium phosphate ceramics – substitutes for the bone mineral hydroxyapatite – are in principle an ideal alternative to conventional metals because bone can eventually replace the ceramic and regrow.
However, applications of such ceramics in medical settings have been limited by insufficient control over the rate of absorption and replacement by bone after implantation.
Now, researchers in Japan have studied the effect of the carbon chain length of a phosphate ester ceramic containing calcium ion on the rate of its transformation into hydroxyapatite mediated by alkaline phosphatase which presents in our bones.
This work will help move regeneration research from laboratories to medical use.
The study by TMDU and collaborating partners was published in Science and Technology of Advanced Materials.
“Medical professionals have long sought a means of healing bone fractures without using implanted medical devices, but the underlying science that can make this dream a reality isn’t yet fully elaborated,” explained lead author Taishi Yokoi.
“Our careful analysis of the effect of the ceramic’s ester alkyl chain length on hydroxyapatite formation, in a simulated body fluid, may help develop a novel bone-replacement biomaterial.”
Two findings
The researchers report two main findings.
First, most of the studied ceramics underwent chemical transformations into particulate or fibrous hydroxyapatite within a few days.
Second, smaller alkyl groups facilitated faster chemical reactions than larger alkyl groups.
Because the rate-limiting step of hydroxyapatite formation is dissolution of the ceramic, the greater solubility imparted by smaller alkyl groups sped up production of hydroxyapatite.
Such knowledge gives a means of tailoring the speed of bone regrowth.
“We now have specific chemical knowledge on how to tailor the rate of hydroxyapatite growth from calcium phosphate ceramics,” says Yokoi.
“We expect that this knowledge will be useful for bench researchers and medical practitioners to more effectively collaborate on tailoring bone reformation rates under medically relevant conditions.”
The results of this study are important for healing bone fractures after surgery.
By using chemical insights to optimise the rate of bone reformation after implantation of calcium phosphate ceramics, patient outcomes will improve, and returns to the hospital years later for further repairs will be minimised.
